ArticleFrontiers in oncology2025
Role of Intermediate dose escalation of radiotherapy in the survival of unresectable stage III non-small cell lung cancer patients in the era of immunotherapy.
Saber A Amin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.